Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in ReceivablesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Gossamer Bio (GOSS) Other Working Capital Changes: 2022-2025

Historic Other Working Capital Changes for Gossamer Bio (GOSS) over the last 4 years, with Sep 2025 value amounting to -$10.2 million.

  • Gossamer Bio's Other Working Capital Changes fell 295.33% to -$10.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$13.1 million, marking a year-over-year decrease of 121.19%. This contributed to the annual value of $55.9 million for FY2024, which is 1336.77% up from last year.
  • Gossamer Bio's Other Working Capital Changes amounted to -$10.2 million in Q3 2025, which was down 251.58% from $6.8 million recorded in Q2 2025.
  • Gossamer Bio's Other Working Capital Changes' 5-year high stood at $65.9 million during Q2 2024, with a 5-year trough of -$10.2 million in Q3 2025.
  • For the 3-year period, Gossamer Bio's Other Working Capital Changes averaged around $5.0 million, with its median value being $801,000 (2024).
  • As far as peak fluctuations go, Gossamer Bio's Other Working Capital Changes plummeted by 462.95% in 2023, and later skyrocketed by 2,346.90% in 2024.
  • Over the past 4 years, Gossamer Bio's Other Working Capital Changes (Quarterly) stood at $691,000 in 2022, then slumped by 462.95% to -$2.5 million in 2023, then crashed by 226.48% to -$8.2 million in 2024, then slumped by 295.33% to -$10.2 million in 2025.
  • Its Other Working Capital Changes stands at -$10.2 million for Q3 2025, versus $6.8 million for Q2 2025 and -$1.4 million for Q1 2025.